Increased Alternative Splicing of the KLF6 Tumour Suppressor Gene Correlates with Prognosis and Tumour Grade in Patients with Pancreatic Cancer

Overview

Journal Eur J Cancer

Specialty Oncology

Date 2008 Aug 12

PMID 18691883

Citations 31

Authors

Mark Hartel

Goutham Narla

Moritz N Wente

Nathalia A Giese

Marc E Martignoni

John A Martignetti

Helmut Friess

Scott L Friedman

Affiliations

Soon will be listed here.

Abstract

The aim of this study was to correlate the status of the KLF6 tumour suppressor gene including loss of heterozygosity (LOH), mutation and alternative splicing in human pancreatic cancer with tumour grade and survival. Whereas neither KLF6 loss nor mutation was identified, expression of the KLF6 alternative splice forms was significantly increased in pancreatic tumour samples and cell lines. These cancers demonstrated marked cytoplasmic KLF6 expression, consistent with over-expression and accumulation of KLF6 splice form(s), which lack a nuclear localisation signal. In addition, KLF6 splicing correlated significantly with tumour stage and survival. In summary, pancreatic cancer displays a novel pattern of KLF6 dysregulation through selectively increased expression of KLF6 splice variants. Therefore, determination of KLF6 mRNA splicing levels may represent a novel biomarker predicting prognosis.

Citing Articles

The Role of Krüppel-like Factors in Pancreatic Physiology and Pathophysiology.

Giarrizzo M, LaComb J, Bialkowska A Int J Mol Sci. 2023; 24(10).

PMID: 37239940 PMC: 10218095. DOI: 10.3390/ijms24108589.

Roles of Krüppel-like factor 6 splice variant 1 in the development, diagnosis, and possible treatment strategies for non-small cell lung cancer.

Hu K, Ma C, Ma R, Zheng Q, Wang Y, Zhang N Am J Cancer Res. 2022; 12(10):4468-4482.

PMID: 36381325 PMC: 9641401.

Investigation of androgen receptor-dependent alternative splicing has identified a unique subtype of lethal prostate cancer.

Seltzer S, Giannopoulos P, Bismar T, Trifiro M, Paliouras M Asian J Androl. 2022; 25(3):296-308.

PMID: 36259569 PMC: 10226513. DOI: 10.4103/aja202263.

ID1 marks the tumorigenesis of pancreatic ductal adenocarcinoma in mouse and human.

Tang Y, Zhang S, Li J, Wu C, Fan Q Sci Rep. 2022; 12(1):13555.

PMID: 35941362 PMC: 9359991. DOI: 10.1038/s41598-022-17827-3.

Isoforms of the orphan nuclear receptor COUP‑TFII differentially modulate pancreatic cancer progression.

Polvani S, Pepe S, Tempesti S, Tarocchi M, Marroncini G, Bencini L Int J Oncol. 2022; 60(5).

PMID: 35348189 PMC: 8997336. DOI: 10.3892/ijo.2022.5345.

References

Lockhart A, Rothenberg M, Berlin J . Treatment for pancreatic cancer: current therapy and continued progress. Gastroenterology. 2005; 128(6):1642-54. DOI: 10.1053/j.gastro.2005.03.039. View

Bieker J . Krüppel-like factors: three fingers in many pies. J Biol Chem. 2001; 276(37):34355-8. DOI: 10.1074/jbc.R100043200. View

Kaczynski J, Cook T, Urrutia R . Sp1- and Krüppel-like transcription factors. Genome Biol. 2003; 4(2):206. PMC: 151296. DOI: 10.1186/gb-2003-4-2-206. View

Yamano M, Fujii H, Takagaki T, Kadowaki N, Watanabe H, Shirai T . Genetic progression and divergence in pancreatic carcinoma. Am J Pathol. 2000; 156(6):2123-33. PMC: 1850062. DOI: 10.1016/S0002-9440(10)65083-3. View

Narla G, DiFeo A, Yao S, Banno A, Hod E, Reeves H . Targeted inhibition of the KLF6 splice variant, KLF6 SV1, suppresses prostate cancer cell growth and spread. Cancer Res. 2005; 65(13):5761-8. DOI: 10.1158/0008-5472.CAN-05-0217. View

Yea S, Narla G, Zhao X, Garg R, Tal-Kremer S, Hod E . Ras promotes growth by alternative splicing-mediated inactivation of the KLF6 tumor suppressor in hepatocellular carcinoma. Gastroenterology. 2008; 134(5):1521-31. PMC: 2600656. DOI: 10.1053/j.gastro.2008.02.015. View

Kremer-Tal S, Reeves H, Narla G, Thung S, Schwartz M, DiFeo A . Frequent inactivation of the tumor suppressor Kruppel-like factor 6 (KLF6) in hepatocellular carcinoma. Hepatology. 2004; 40(5):1047-52. DOI: 10.1002/hep.20460. View

Kojima S, Hayashi S, Shimokado K, Suzuki Y, Shimada J, Crippa M . Transcriptional activation of urokinase by the Krüppel-like factor Zf9/COPEB activates latent TGF-beta1 in vascular endothelial cells. Blood. 2000; 95(4):1309-16. View

Cho Y, Kim C, Park C, Yang Y, Kim S, Nam S . Genetic alterations of the KLF6 gene in gastric cancer. Oncogene. 2005; 24(28):4588-90. DOI: 10.1038/sj.onc.1208670. View

10.

Schuh R, Aicher W, Gaul U, Cote S, Preiss A, Maier D . A conserved family of nuclear proteins containing structural elements of the finger protein encoded by Krüppel, a Drosophila segmentation gene. Cell. 1986; 47(6):1025-32. DOI: 10.1016/0092-8674(86)90817-2. View

11.

Burris 3rd H, Moore M, Andersen J, Green M, Rothenberg M, Modiano M . Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol. 1997; 15(6):2403-13. DOI: 10.1200/JCO.1997.15.6.2403. View

12.

Garcea G, Neal C, Pattenden C, Steward W, Berry D . Molecular prognostic markers in pancreatic cancer: a systematic review. Eur J Cancer. 2005; 41(15):2213-36. DOI: 10.1016/j.ejca.2005.04.044. View

13.

Koritschoner N, Bocco J, Panzetta-Dutari G, Dumur C, Flury A, Patrito L . A novel human zinc finger protein that interacts with the core promoter element of a TATA box-less gene. J Biol Chem. 1997; 272(14):9573-80. DOI: 10.1074/jbc.272.14.9573. View

14.

Wada K . p16 and p53 gene alterations and accumulations in the malignant evolution of intraductal papillary-mucinous tumors of the pancreas. J Hepatobiliary Pancreat Surg. 2002; 9(1):76-85. DOI: 10.1007/s005340200007. View

15.

Slavin D, Koritschoner N, Prieto C, Lopez-Diaz F, Chatton B, Bocco J . A new role for the Kruppel-like transcription factor KLF6 as an inhibitor of c-Jun proto-oncoprotein function. Oncogene. 2004; 23(50):8196-205. DOI: 10.1038/sj.onc.1208020. View

16.

Benzeno S, Narla G, Allina J, Cheng G, Reeves H, Banck M . Cyclin-dependent kinase inhibition by the KLF6 tumor suppressor protein through interaction with cyclin D1. Cancer Res. 2004; 64(11):3885-91. DOI: 10.1158/0008-5472.CAN-03-2818. View

17.

Kim Y, Ratziu V, Choi S, Lalazar A, THEISS G, Dang Q . Transcriptional activation of transforming growth factor beta1 and its receptors by the Kruppel-like factor Zf9/core promoter-binding protein and Sp1. Potential mechanisms for autocrine fibrogenesis in response to injury. J Biol Chem. 1998; 273(50):33750-8. DOI: 10.1074/jbc.273.50.33750. View

18.

Chen C, Hyytinen E, Sun X, Helin H, Koivisto P, Frierson Jr H . Deletion, mutation, and loss of expression of KLF6 in human prostate cancer. Am J Pathol. 2003; 162(4):1349-54. PMC: 1851229. DOI: 10.1016/S0002-9440(10)63930-2. View

19.

Heinmoller E, Dietmaier W, Zirngibl H, Heinmoller P, Scaringe W, Jauch K . Molecular analysis of microdissected tumors and preneoplastic intraductal lesions in pancreatic carcinoma. Am J Pathol. 2000; 157(1):83-92. PMC: 1850206. DOI: 10.1016/S0002-9440(10)64520-8. View

20.

Glinsky G, Glinskii A, Stephenson A, Hoffman R, Gerald W . Gene expression profiling predicts clinical outcome of prostate cancer. J Clin Invest. 2004; 113(6):913-23. PMC: 362118. DOI: 10.1172/JCI20032. View